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The HIV epidemic in Ukraine 
Ukraine’s first case of HIV was registered 
in 1987. The epidemic began spreading 
rapidly in 1994, when the first case of HIV 
was identified in an injecting drug user 
(IDU) in Mykolayiv.
Ukraine has the highest prevalence of 
HIV/AIDS and the fastest-growing AIDS 
epidemic in all of Europe. The number 
of registered cases of HIV rose by 36% 
between 2003 and 2005. Without 
intervention, the total number could reach 
820,000 or 3.5% of the adult population 
by 2014. At that point, AIDS would be 
the cause of death for one in three male 
adults between the ages of 15 and 49.
Injecting drug users are the primary risk 
group for HIV infection, accounting for 
60% of all cumulative HIV cases as of 
January 2005. Meanwhile, the number of 
people infected with HIV through sexual 
contact is growing.
Cases of HIV have been reported in all 
regions of Ukraine. The highest incidence 
as of January 2005 was in Odesa oblast, 
with 432 cases per 100,000. Other areas 
with high incidence include Mykolayiv, 
Dnipropetrovsk, Donetsk, and Cherkasy 
oblasts, Crimea, and the cities of 
Sevastopol and Kyiv. 
What hinders an effective attack 
on HIV/AIDS?
Many consider the lack of administrative 
capacity and the absence of coordination 
among donors and ministries to be major 
hurdles in implementing HIV/AIDS 
programs. For example, the persecution of 
drug users by law enforcement agencies 
complicates the delivery of prevention and 
treatment services, and harm reduction 
measures.
There is a huge gap between AIDS-related 
law and actual practice in Ukraine. For 
instance, the AIDS law stipulates that 
treatment with antiretroviral (ARV) 
drugs and other medical care should 
be accessible to all, free of charge. In 
practice, this is far from the case. People 
living with HIV/AIDS reportedly are 
asked to pay for diagnostic tests and the 
treatment of opportunistic infections.1 
Donor funds are not always applied 
effectively in Ukraine. For example, in 
April 2006, the World Bank announced 
that it would suspend a US $60 million, 
four-year project to stop the spread of HIV 
and tuberculosis (TB) because Ukraine’s 
Government had failed to distribute funds 
and implement programs. This suspension 
was lifted in November 2006 on condition 
that Ukraine improve project management 
and speed up the implementation of 
its programs. In 2004, the Global Fund 
withdrew a two-year government grant 
of US $25 million and transferred it 
to the management of the International 
HIV/AIDS Alliance (IHAU) in Ukraine.
Insufficient funding has also affected 
the response to HIV/AIDS to date, and 
there are significant gaps in resources 
despite considerable support from 
international donors. Because the policy-
formulation process does not take budgets 
into account, many proposed HIV/AIDS 
programs are little more than items on 
“wish lists.” The Government has also been 
reluctant to make financial commitments 
to continue treatment beyond 2008, when 
the Global Fund grant period ends.
The new Global Fund grant, which focuses 
on prevention, is expected to cover only 
24% of the financial gap for 2007–2011, 
so Ukraine’s Government must be prepared 
to increase its own funding for treatment 
and related programs.
Discrimination against PLHAs
Efforts to control HIV/AIDS are also 
compromised by frequent violations 
of human rights. 75% of the country’s 
HIV-positive people are unaware of their 
HIV status, and most of the population has 
limited knowledge about the HIV infection 
and how to protect themselves against 
transmission.
HIV tests are often administered without 
consent, particularly in TB hospitals and 
drug clinics. Despite a confidentiality clause 
in Ukraine’s national HIV/AIDS law, medical 
staff often disclose a patient’s HIV-positive 
status to relatives or employers without the 
individual’s consent.
People living with HIV/AIDS are often 
denied jobs or dismissed from their 
employment and are refused care or given 
substandard care in medical facilities. 
A survey of HIV-positive pregnant women 
revealed that medical personnel pressured 
the majority to abort their pregnancies. 
In terms of the incidence of HIV/AIDS and the pace of growth of the AIDS 
epidemic, Ukraine continues to be in first place in Europe. An estimated 
410,000 people, 1.4% of the population, are living with HIV/AIDS. Ukraine’s 
political leaders have declared their commitment to controlling HIV/AIDS 
and protecting the rights of people living with HIV/AIDS (PLHA). But the 
government’s efforts have not been entirely successful and the epidemic 
continues to spread rapidly. As part of the “Public Health Watch” project,
ICPS experts held consultations and interviews with representatives of 
civil society. The results were used to draft Government recommendations 
that identify the areas that need improvement in terms of developing, 
implementing and monitoring HIV/AIDS policy
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1 Opportunistic infections are infections caused by organisms that usually do not cause disease in a 
person with a healthy immune system, but can affect people with a poorly functioning or suppressed 
immune system.
icps newsletter is a weekly publication of the International 
Centre for Policy Studies, delivered by electronic mail. 
To be included in the distribution list, mail your request to:
marketing@icps.kiev.ua.
icps newsletter editor: Olha Lvova (olvova@icps.kiev.ua)
Phone: (380-44) 484-4400. Fax: (380-44) 484-4402
English text editor: L.A. Wolanskyj
Articles may be reprinted with ICPS consent.
The International Centre for Policy Studies is an independent 
research organization whose mandate is to promote the 
introduction of public policy concepts and practices in Ukraine. 
This is achieved by increasing the know-how of key government 
officials for policy choices, formulation and debate, and the 
awareness of the public-at-large of the benefits of policy.
Address: vul. Pymonenka 13A, Kyiv, Ukraine 04050
Web-site: http://www.icps.com.ua/eng/
What can be done?
The Ukrainian Government could 
respond to the HIV/AIDS epidemic more 
comprehensively and effectively by:
1. Prioritizing and increasing funding for 
HIV/AIDS to close an anticipated budget 
gap of more than US $464 million for 
2007–2011 and ensuring the effective use 
and management of resources, including by:
• closely linking policy development and 
budgeting processes to ensure the full 
financing and implementation of all 
proposed programs to control HIV/AIDS;
• enhancing transparency in drug-
procurement processes, for example, 
through the inclusion of community 
representatives on tender committees;
• improving administrative capacity and 
processes to avoid future suspensions 
or delays in the disbursement of donor 
funding. 
2. Significantly expanding community 
involvement in planning, implementing 
and monitoring HIV/AIDS programs, 
including by:
• increasing the capacity of the National 
Coordination Council to Prevent the 
Spread of HIV/AIDS, set up in 2005 
to ensure effective coordination 
among sectors in order to encourage 
participation and transparency; 
• engaging NGOs in the provision of 
HIV testing and other services and in 
outreach to marginalized populations. 
3. Ensuring equal access to prevention, 
treatment, care, and support services for 
marginalized populations, such as IDUs, sex 
workers, prisoners, and men who have sex 
with men (MSMs) by:
• eliminating police quotas for drug-
related arrests, which contribute to 
police intrusions in HIV/AIDS prevention 
and treatment centers; 
• addressing discrimination in healthcare 
settings by offering regular training for 
healthcare workers; 
• integrating HIV/AIDS, TB and drug-
dependency treatment more effectively 
to allow clients to access comprehensive 
care for all three services in one setting 
and also offering coordinated treatment 
and care for active drug users and those 
who are coinfected with TB/HIV or triply 
affected;
• improving HIV/AIDS services in 
prisons, such as by providing condoms 
and clean injection supplies and by 
building capacity for the rapid rollout 
of ARV treatment and treatment for 
opportunistic infections. 
4. Contributing to effective and large-scale 
treatment with antiretroviral medications 
(ARV)2 and treatment for opportunistic 
infections by:
• ensuring free ARV treatment and other 
services for PLHAs, as stipulated in 
the National HIV/AIDS Program, by 
eliminating the “hidden” costs of 
treatment, such as fees for diagnostic 
tests and the treatment of opportunistic 
infections and transportation costs; 
• coordinating procurement between 
national and regional governments 
to avoid the underfinancing of 
commodities and stock-outs; 
• recruiting and training more HIV/AIDS 
specialists and ensuring full adherence 
to HIV/AIDS treatment regimes.
5. Scaling up substitution therapy3 to 
ensure access to the estimated 60,000 to 
238,000 drug users in need of substitution 
therapy, in order to slow the spread of 
HIV and to maximize the effectiveness 
of ARV treatment and the treatment of 
opportunistic infections for drug users, by:
• ensuring funding of substitution therapy 
is supported by the overall health budget 
rather than limited to the HIV/AIDS 
budget; 
• allowing substitution therapy in 
hospitals in order to ensure that people 
can seek the care they need without 
being subjected to forced detoxification 
and can receive the treatment they need 
without interruption; 
• following through on the rollout of 
methadone substitution therapy in 2007 
and considering plans for this cheaper 
form of substitution therapy to be made 
widely available; 
• referring drug users who are in 
possession of a small amount of 
drugs without intending to resell or 
redistribute it to substitution therapy or 
other appropriate treatment programs, 
rather than incarcerating them. 
6. Encouraging more people to test for HIV, 
particularly members of high-risk groups, 
such as IDUs and sex workers, by: 
• increasing the number of counseling 
and testing sites, particularly in rural 
areas, and ensuring that these sites and 
other institutions, such as drug clinics 
and TB hospitals, offer voluntary and 
confidential testing and pre- and post-
test counseling; 
• eliminating the current procedure of 
requiring HIV-positive people to sign 
a written release accepting criminal 
responsibility; 
• allowing NGOs to play a greater role in 
testing, for example, by encouraging 
partnerships with hospitals and testing 
sites and by repealing legislation that 
prohibits NGOs from testing; 
• establishing and strengthening 
mechanisms to protect people from all 
forms of discrimination and breaches of 
confidentiality, and providing outlets to 
lodge complaints, pursue legal action, 
and receive compensation for damages. 
7. Launching a public awareness campaign 
to inform people properly about HIV 
transmission, the availability of testing 
and services, and the importance of 
battling stigmatization and discrimination; 
ensuring wide, effective dissemination 
of accurate and up-to-date information, 
including by:
• assessing the impact of efforts on public 
awareness and behavior; 
• enforcing legislation that requires 
media outlets to dedicate at least 5% 
of advertising space to public service 
announcements by NGOs; coordinating 
HIV/AIDS-related public service 
announcements to avoid contradictory 
messages. 
The report called “Public Watch of the 
Government HIV/AIDS Policy in Ukraine” 
can be downloaded (in Ukrainian) from the 
ICPS website. The “Public Health Watch” 
project was financed by the Open Society 
Institute’s program of the same name. 
The author is Andriy Bega, a policy analysis 
consultant at the ICPS (Kyiv, Ukraine). 
For additional information, contact Oksana 
Tsisyk by telephone at (380-44) 484-4400 
or via e-mail at otsisyk@icps.kiev.ua.
2 Antiretroviral drugs (ARV drugs) are medical substances that slow down the development of HIV 
and prevent the collapse of the immune system. 
3 Substitution therapy is a form of medical care that is based on applying a similar or identical 
substance in the treatment of opioid addiction. 
